Targeting Muscle Metabolism Rather Than Appetite Instead of acting on hunger pathways, the new compound boosts metabolic activity directly within skeletal muscle
Signs that your dose may be too high include persistent severe nausea that does not improve after two weeks at the current dose, inability to eat more than a few bites at each meal, significant fatigue or weakness, and rapid weight loss exceeding 2% of body weight per week consistently
If you experience any sudden swelling in the neck, difficulty swallowing, or persistent hoarseness, seek urgent medical attention from your GP or call 999/A&E if symptoms are severe
GLP-1 receptor agonists like semaglutide reduce appetite by slowing stomach emptying and signaling fullness to your brainbut eating the wrong foods can interfere with this process and cause unnecessary side effects
When pregnancy is recognized, discontinue SAXENDA
By activating GLP-1 receptors, semaglutide helps individuals feel fuller on smaller portions, reducing snacking between meals and dampening the constant mental pull towards food that many people experience